MS

Manoj Singla

Active Director Director DIN 11347566
DIN 11347566 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value •••• Premium profile

About Manoj Singla

Data last updated:

Manoj Singla is a Director at Xieon Life Sciences Private Limited (since 2025). The company operates in Pharma. Xieon Life Sciences Private Limited reported revenue of ₹43.18 Cr (FY 2024).

DIN 11347566
Primary Designation Director
Industry Pharma
First Appointment 10 Oct 2025
Largest company Xieon Life Sciences Private Limited · ₹43.18 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xieon Life Sciences Private Limited U51101DL2007PTC159289
Director10 Oct 2025₹43.18 Cr (FY 2024)Active

Board colleagues of Manoj Singla

Directorship timeline

Open interactive timeline →
Xieon Life Sciences Private Limited
Premium access

Shareholding and investment profile for Manoj Singla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manoj Singla

Manoj Singla currently holds 1 directorship: Xieon Life Sciences Private Limited (Director, since 10 Oct 2025, revenue ₹43.18 Cr (FY 2024)).

Manoj Singla was first appointed on 10 Oct 2025 as Director at Xieon Life Sciences Private Limited.

The current boards of Manoj Singla's companies include Ankur Goyal (Xieon Life Sciences Private Limited), Ashok Bambha (Xieon Life Sciences Private Limited), Yogesh Singla (Xieon Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available